stars 1 stars 2 stars 3

PersisGen is a specialized biopharmaceutical R&D partner dedicated to accelerating the development of innovative biologics from early-stage research to manufacturing readiness. We provide end-to-end scientific and technical solutions across process development, technology transfer, CMC strategy, process validation, and manufacturing support. Our expertise spans recombinant proteins, monoclonal antibodies, biosimilars, vaccines, and next-generation biologics. At PersisGen, we bridge the gap between scientific discovery and commercial manufacturing by combining deep technical expertise with real-world industrial experience. We help biotech and pharmaceutical companies de-risk complex development challenges, optimize processes, and accelerate the path from innovation to life-changing therapies.

PersisGen Questions

Hamideh Aghajani is the CEO of PersisGen.

33 people are employed at PersisGen.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users